Cytotoxicity and genotoxicity of calcium silicate-based cements on an osteoblast lineage Abstract: Several calcium silicate-based biomaterials have been developed in recent years, in addition to Mineral Trioxide Aggregate (MTA). The aim of this study was to evaluate the cytotoxicity, genotoxicity and apoptosis/necrosis in human osteoblast cells (SAOS-2) of pure calcium silicate-based cements (CSC) and modified formulations: modified calcium silicate-based cements (CSCM) and three resin-based calcium silicate cements (CSCR1) (CSCR 2) (CSCR3). The following tests were performed after 24 hours of cement extract exposure: methyl-thiazolyl tetrazolium (MTT), apoptosis/necrosis assay and comet assay. The negative control (CT-) was performed with untreated cells, and the positive control (CT+) used hydrogen peroxide. The data for MTT and apoptosis were submitted to analysis of variance and Bonferroni's posttest (p < 0.05), and the data for the comet assay analysis, to the Kruskal-Wallis and Dunn tests (p < 0.05). The MTT test showed no significant difference among the materials in 2 mg/mL and 10 mg/mL concentrations. CSCR3 showed lower cell viability at 10 mg/mL. Only CSC showed lower cell viability at 50 mg/mL. CSCR1, CSCR2 and CSCR3 showed a higher percentage of initial apoptosis than the control in the apoptosis test, after 24 hours exposure. The same cements showed no genotoxicity in the concentration of 2 mg/mL, with the comet assay. CSC and CSCR2 were also not genotoxic at 10 mg/mL. All experimental materials showed viability with MTT. CSC and CSCR2 presented a better response to apoptosis and genotoxicity evaluation in the 10 mg/mL concentration, and demonstrated a considerable potential for use as reparative materials.
Elisandra Márcia RODRIGUES (a) Leticia Boldrin MESTIERI (a) Thaís de Oliveira Rodrigues Sanzovo FALCOSKI (b) Christiane Pienna SOARES (b) Juliane Maria GUERREIRO-TANOMARU (a) Carlos ROSSA JUNIOR (c) Mário TANOMARU-FILHO (a) Introduction An innovative repair material was developed in 1993 at the University of Loma Linda, called Mineral Trioxide Aggregate (MTA).
1 MTA has been used successfully for apexification, internal root resorption, endodontic surgery, sealing of perforations, and as a pulp-capping material. 2 Fine particles of tricalcium silicate, tricalcium aluminum, tricalcium oxide and other oxide materials, in addition to bismuth oxide, which promotes the radiopacity of cement, make up the composition of MTA powder, which sets on contact with water. 3 MTA is a non-cytotoxic reparative material with excellent biological properties. 4 MTA contributes to reducing inflammation and necrosis levels. The use of MTA as pulp-capping material induces the formation of a dentin bridge, allowing repair and pulp vitality. 5 Various studies have shown that the physicochemical and biological properties of MTA are similar to those of Portland Cement (PC), a calcium silicate-based cement (CSC). 6, 7 Calcium silicate based cements (CSC) have the potential to stimulate cell proliferation and osteoblast-related gene expression in osteoblasts. 8, 9 Anti-inflammatory effects and dentinogenic potential have been observed in primary pulp cells and mouse dental papilla cell-23 (MDPC-23) cells exposed to CSC cements, respectively.
10,11
The fluid and granular consistency of MTA and its elevated setting time make its clinical use difficult. Additives are used to increase the plasticity of CSCs, and thus facilitate material handling. 12 Different formulations of this cement, modified with additives and resins, have been proposed to improve the manipulation and consistency of the cement, and have ultimately given rise to modified calcium silicate cements (CSCMs) and resin calcium silicate cements (CSCRs). The addition of 2% and 5% calcium chloride to Portland cement has promoted better setting times, and a biocompatibility similar to that of MTA. 13 A newly proposal material called calcium silicate-gelatin cement has presented a better setting time, work time and flow than MTA ProRoot. This material has also provided suitable results in regard to proliferation and differentiation of dental pulp cells. 14 Bosso-Martelo et al. 15 evaluated the physicochemical properties of calcium silicate cements with additives and resins. Some combinations of silicate-based cements and different radiopacifiers have provided a shorter final setting time, low solubility, alkaline pH and calcium ion release. In a recent study, the addition of fluoride-containing radiopacifier ytterbium trifluoride (YbF3) improved the micromechanical and biological characteristics of modified calcium silicate cements, without modifying osteoclast and osteoblast-like cell integrity. 16 The biological properties of new cement formulations must be studied for possible application in dentistry. Reparative materials used in contact with periodontal or pulp tissues should not present cytotoxicity or genotoxicity, thereby favoring the repair process. 17, 18 Genotoxicity describes the property of a chemical agent that damages the genetic information within a cell, causing mutations. Ribeiro et al. 19 also showed that regular and white mineral trioxide aggregate (MTA) cements presented no cytotoxicity and genotoxicity when mouse lymphoma cells were exposed to them, according to the trypan blue and comet assays, respectively. Similar results with Portland cement have shown that none of these materials were cytotoxic when evaluated alone or in association with radiopacifying agents. 20, 21 The aim of this study was to investigate whether the new formulations of pure and modified calcium silicate-based cements induced some type of damage to human osteosarcoma cells (Saos-2). The MTT and apoptosis assays were performed on cement extracts, and the genotoxicity effects were evaluated by comet assay, to monitor the cytotoxic effects.
Methodology Cell Culture
Human osteoblast cells (SAOS-2 line ATCC HTB-85) were grown as a monolayer culture in T-75 flasks (Corning, Union City, USA) containing Dulbecco Modified Eagle Medium (DMEM-Sigma/Aldrich, St. Louis, USA) supplemented with 10% fetal bovine serum (FBS), penicillin (100 IU/mL), and streptomycin (100 mg/mL) until confluent. The cells were subcultured twice a week at 37 °C, 95% humidity and 5% CO 2 . Adherent cells in logarithmic growth phase were detached by a mixture of trypsin/EDTA (0.25%) at 37 °C for 3 minutes.
Preparation of extracts
The study procedure followed the methodology described by Gomes-Cornélio et al. 21 One gram of each experimental cement was weighed and manipulated with distilled water, in the recommended proportions, on sterile glass plates (Table) . After manipulation, the materials were weighed (1 g) again, and placed in 50 mL Falcon tube lids. All the materials were duly identified, imbibed with damp sterile gauze and taken to the laminar flow chamber, where they remained for 30 minutes under UV light to prevent contamination. After this period, the Falcon tubes were filled with 10 mL of DMEM culture medium containing 10% FBS, the cement-filled lids were fitted onto each tube, which was inverted, so that the materials would come into contact with the culture medium; the tubes were then placed in an oven at 37 °C, 95% humidity and 5% CO 2 , for 3 hours. Three eluates were selected, as recommended by a previous study, 21 and prepared after contact of the materials with the culture medium: 50 mg/mL, 10 mg/mL and 2 mg/mL before cell exposure.
MTT assay
This assay consists of determining how well the mitochondrial dehydrogenase enzyme converts the water-soluble yellow salt [3-(4,5-dimethyl-thiazoyl)-2,5-diphenyl-tetrazolium bromide -MTT; Sigma/ Aldrich] into colored formazan compounds, whose absorbance is proportional to the quantity of live cells. A number of 1 x 10 5 cells/mL were plated in 24-well culture plates, in triplicate.
After remaining 24 hours in the cell culture with the 3 different eluates of each cement and the controls (C+: 3% hydrogen peroxide, and C-: negative control = cells without treatment), the eluates were aspired and replaced with 900 µl of D-MEM and 5 mg/mL MTT salt, and the plates were incubated for an additional 3 h, in an oven at 37 °C, 95% humidity and 5% CO 2 . After this period, each well was washed with 1 mL of phosphate buffer (PBS 1X) and aspirated. Then 500 µl of acidified isopropyl alcohol (HCl: isopropyl alcohol, 0.04N) was added to the extract to solubilize the formazan crystals. The samples were transferred to a 96-well plate for readout in triplicate.
The optical density (OD) was measured by an automatic microplate reader (ELx800; BioTek Instruments, Winooski, USA) and submitted to statistical analysis by the variance test (ANOVA), with Bonferroni's posttest (p < 0.05). Three repetitions of the experiment were performed.
Comet assay Preparation of Slides
A number of 2 x 10 6 cells/mL were plated in 24-well culture plates, in triplicate. After 24 hours, the cells were exposed to the 3 different cement eluates and kept in an oven at 37 °C, 95% humidity and 5% CO 2 , for an additional 24 hours. The experiment was based on the technique described by Sigh et al. 22 After treatment of the cells with the different cement extracts, 200 μl of trypsin/0.25% EDTA (Sigma/Aldrich) was added to each well of the plate for 2 min to detach the cells. After centrifugation (2000 rpm/3 min), each group of cells was resuspended in 200 μl of agarose LMP (low melting point, Sigma/Aldrich) and transferred to slides recently prepared with 1.5% agarose (Sigma/Aldrich). The slides were immersed in lysis solution (NaCl 2.5 M, EDTA 100mM, Tris 10 mM/ 1% Triton X-100, 10% DMSO) and kept at 4 °C overnight. SAOS-2 cells treated with H 2 O 2 (1mM) were used as the positive control.
Electrophoresis
The prepared slides were organized in a horizontal electrophoresis cube, and left in the electrophoresis solution (10 mL 0.2M EDTA + 60 mL 10M NaOH, pH13, to complete 2000 mL milliQ H 2 0) for 20 minutes to allow DNA unwinding. The source was set to 25 V, and the run continued for another 20 minutes. The slides were removed, immersed in a neutralizing solution (0.4M Tris pH7.5) for 15 min, fixed in pure ethanol, and left to dry at room temperature.
Staining and Analysis
An 80 μl volume of ethidium bromide (0.02 mg/mL) was added to stain the slides, and the readouts were immediately taken under a fluorescence microscope (Nikon Corporation, Tokyo, Japan) at 400x magnification. Counts of 100 cells/group were made, and each selected field was photographed. The images were analyzed in the Comet Score software program, and statistically analyzed by the Graphpad Prism 5.03 software program. The counted cells were analyzed, and the same group of materials was compared with both the positive and the negative controls.
The Kruskal-Wallis and Dunn (p < 0.05) tests were performed for the purpose of statistical analysis.
Apoptosis Assay
A number of 1x10 6 SAOS-2 cells were plated on 24-well culture plates, after remaining in contact with the cement eluates (10 mg/mL). The test was performed with the FITC Annexin V Apoptosis Detection Kit I (BD Biosciences, Pharmingen, San Jose, USA) in a 24-hour period. Afterwards, the cells were washed and collected from the culture plate wells containing nonenzymatic reagent (cell dissociation buffer -Gibco/Carlsbad, California, USA), resuspended in binding buffer 1X (0.1 M Hepes/NaOH; 1.4M NaCl; 25mM CaCl 2 -pH: 7.4), and then stained with apoptosis markers: FITC Annexin V and/or PI (propidium iodide staining solut ion) -50μg/mL; these same cells also underwent unmarked controls and the positive control (Camptothecin 1mM-Sigma/Aldrich). All the Eppendorf tubes were incubated in a dark environment for 15 min, and 400 μl of 
Results

MTT assay
The cements evaluated presented biocompatibility, with results similar to those of the negative control group (p < 0.05), except for CSC 50 mg/mL and CSCR3 10 mg/mL, as shown in Figure 1 .
Comet Assay
All of the CSCs evaluated, with the exception of the pure CSC, presented genotoxicity in the concentration of 50 mg/mL, compared with the control, whereas CSC and CSCR2 presented no genotoxicity in the concentration of 10 mg/mL, compared with the negative control. In the last concentration of 2 mg/mL, all the cements, except for CSCM, were similar to those of the negative control group (p < 0.05), (Figure 2 ).
Apoptosis Assay
Histograms were used to represent the percentage of viable osteoblast cells (SAOS-2), and analyze the initial and final stage of apoptosis and necrosis, within a 24-hour period. In regard to cell viability, groups CSCR1 and CSCR2 were found to be similar to the negative control (cells without treatment), unlike CSCR3, which displayed low cell viability (p < 0.05). Groups CSC and CSCM presented slightly higher viability values than those of the negative control. In the initial stage of apoptosis, all the groups were found to be different from the negative control, with higher percentages, and the CSCR3 group showed a higher rate of initial apoptosis (p < 0.05). The experimental groups showed lower values of late apoptosis and necrosis, compared with the negative control (p < 0.05), (Figure 3 ).
Discussion
Additives have been incorporated into Portland cement to improve its physical and chemical properties. New calcium silicate-based cements have also been studied, 23, 24 and some of the modified calcium silicate and resin cements under study may present the potential for clinical use. CSCM is a modified calcium silicate cement that contains mineral aggregates, additives and pigments. Resin calcium silicate cements (CSCRs) not only have mineral aggregates, additives and pigments, but also resin components in their composition, aimed at improving their manipulation and setting time. However, the addition of composites in cements may interfere and harm their biological properties and bioactivity. 13 The immortalized osteoblast cell lineage was used in this study, because of its reproducibility capabilities, and because its relationship with the bone repair process in tissues 25, 26 makes it ideal for vitro assays researching new endodontic and retrofilling materials. Modareszadeh et al. 27 evaluated , and reported the importance of these cells in the mineralization and repair process. Gandolfi et al. 28 confirmed that calcium silicate-based cements and MTA are good substrates for osteoblast growth, and induce cell proliferation, even when fresh cements are used, as was done in the present study.
The results of the present study showed that calcium silicate-based cements did not present cytotoxicity, compared with the positive control (3% hydrogen peroxide), and were similar to the negative control (untreated cells) particularly in the concentrations of 10 mg/mL and 2 mg/mL. Favorable results have been observed for pure and/or modified calcium silicate-based cements, either associated with radiopacifying agents, or not. 21, 29 A newly developed CSC, with zirconium oxide (ZrO 2 ), named Ortho-MTA (OMTA; BioMTA, Seoul, Korea) has promoted an inflammatory response and odontoblastic differentiation similar to Biodentine and MTA Angelus in human dental pulp cells (hDPCs). 30 Furthermore, CSC has been found to stimulate osteogenesis in a co-culture of macrophage cells (Raw 264.7) and osteoblast cells (MC3T3-E1), with improved proliferation and higher calcium deposition than cells in a monoculture. 31 In our recent study, the silicate-based cement associated with ZrO 2 exhibited a viability rate similar to that of MTA Plus and Biodentine in osteoblast-like cells. 32 However, the MTT assay could show a false-positive result, 33 thus making it important to perform other cytotoxicity tests.
Some studies have shown that MTA does not induce significant apoptosis and/or necrosis in distinct cell lineages. 33, 34 The flow cytometry experiment using the FITC Annexin V Apoptosis Detection Kit I (BD Biosciences) was used to analyze the following: intact cells; cells in initial apoptosis, where FITC binds to phosphatidylserine (a component of the cell membrane), which is found inverted in the cells at this stage; and cells in final apoptosis and necrosis. In this final stage, in addition to the positive binding of FITC, there is also the binding of PI (propidium iodide) to the genetic material of the cell, since the membrane is completely damaged at this stage of cell death, thus allowing entry of the marker. Gorduysus et al. 35 used the same methodology to evaluate the type of cell death of human fibroblasts in different endodontic materials. MTA behaved in a manner very similar to that of the control, with high percentages of viable cells; however, the materials tested [Diaket (ESPE, Seefeld, Germany) Endion (VOCO, Cuxhaven, Germany) and CYMED 8410 (NANO, Kaohsiung, Taiwan)] induced high percentages of apoptosis and necrosis, in comparison with the control.
CSCR1 and CSCR2 were similar to the control as regards cell viability, unlike CSCR3, which had a lower percentage of cell viability (p < 0.05). Groups CSC and CSCM presented higher viability values than those of the negative control (p < 0.05). All the experimental groups induced initial apoptosis, but not late apoptosis or necrosis, compared with the control (p < 0.05). It is known that endoplasmic reticulum stress caused by an excess of Ca +2 ions may lead to apoptosis; 36 this could be one of the explanations for why the groups treated with different calcium silicate-based cements had a rapid onset of apoptosis. Eid et al. 37 also found a higher percentage of apoptosis in cells exposed to the calcium silicate-based MTA Plus and MTA Angelus materials, suggesting that the initial sites of irreversible damage by cytotoxic agents are extracellular, while the nuclear membranes of these cells still remain intact.
The comet assay suggested damage to DNA, chromosome breakage, altered DNA repair and cellular transformation. 20 Among the various parameters calculated by this method, one of the most widely used indicators of DNA damage is the length of the comet tail, which is a virtual measurement calculated by the computed image analysis system, considering both the duration of DNA migration in the comet tail and the intensity of the tail. 38 The results of this study revealed that CSC and CSCR2 performed outstandingly in the concentration of 10 mg/mL, since they presented no genotoxicity compared with the negative control. These results for pure CSC corroborate those of other studies that have demonstrated its biocompatibility. 19, 20, 21 The low genotoxic risk associated with a new cement based on dicalcium-and tricalcium-silicate (CS) with hydroxyapatite (HA) was observed using the comet assay and human peripheral blood lymphocytes. 39 Biosilicate® analysis of genotoxicity showed no DNA damage in lineages, osteoblasts or fibroblasts, in all the evaluation periods (24, 72, and 96 hours). 40 The different modified CSCs presented appropriate cell viability results. A high number of living cells were preserved in the cells exposed to CSCs, although the percentage of apoptosis increased slightly.
Genotoxicity analysis indicated that the CSCs did not induce DNA damage in osteoblast-like cells (Saos-2) at the highest CSC dilution. These results suggest that CSCs have a good potential for use as a reparative material. However, additional studies are needed to research new CSCs.
